Monday 18 Aug, 2025 04:23 PM
Site map | Locate Us | Login
   Marksans Pharma rises as UK subsidiary gets approval for Metformin Prolonged release tablets    Knowledge Marine & Engg jumps on bagging Rs 28-cr order    Indostar Capital Finance gains on appointing Amit Kumar Khan as COO    Godfrey Phillips India Ltd leads losers in 'A' group    Agarwal Industrial Corporation Ltd leads losers in 'B' group    Kothari Industrial hits the roof as net loss narrows in Q1    Volumes spurt at K E C International Ltd counter    Kwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico    SEPC rises after Q1 PAT spurts 105% YoY to Rs 17 cr    Bajaj Finserv Ltd gains for third straight session    Bajaj Finance Ltd spurts 6.12%    Eicher Motors Ltd up for third straight session    TVS Motor Company Ltd soars 6.13%, up for third straight session    Ashok Leyland Ltd rises for third consecutive session    AU Small Finance Bank Ltd rises for third straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Kwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico
18-Aug-25   14:05 Hrs IST

According to an exchange filing, Bleomycin is a widely used anti-cancer medicine, effective in the treatment of Hodgkin's lymphoma, testicular cancer, and certain squamous cell carcinomas. This approval further strengthens our expansion into highly regulated markets, reinforcing our commitment to delivering quality oncology products globally.

The projected business potential is approximately $1 million in the first year, and supplies are expected to commence before the end of Q2 FY26.

The company stated that it remains committed to expanding access to high-quality medicines across global markets.

Kwality Pharmaceuticals is engaged in the business of manufacturing & trading in pharmaceuticals & allied products.

The company's consolidated net profit surged 42.7% to Rs 11.93 crore on 39.2% rise in revenue from operations to Rs 111.48 crore in Q1 FY26 over Q1 FY25.

The counter slipped 3.37% to Rs 1,033.05 on the BSE.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure Hit Count : 43535022
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited